• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威稳定期肾移植患者的心血管疾病:5年随访期间的发病率和死亡率

Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.

作者信息

Aakhus Svend, Dahl Ketil, Widerøe Tor Erik

机构信息

Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway.

出版信息

Clin Transplant. 2004 Oct;18(5):596-604. doi: 10.1111/j.1399-0012.2004.00235.x.

DOI:10.1111/j.1399-0012.2004.00235.x
PMID:15344967
Abstract

BACKGROUND

Although cardiovascular disease is a major cause of death after renal transplantation (Tx), predictors for cardiovascular events have not been well defined. Aims of this cross-sectional study were first to assess cardiovascular morbidity and mortality in stable renal Tx patients, and to identify predictors for cardiovascular events during long-term follow-up.

METHODS

In all, 406 renal Tx patients (mean age: 47 yr, 60.1% males, 70.9% using cyclosporine A) commenced a baseline registration (median) 48 months after Tx, and 405 was thereafter followed in 5 yr. Kaplan-Meier plots and multivariate regression analysis (Cox proportional hazards model) were used to identify and characterize predictors for cardiovascular events.

RESULTS

There were 88 deaths (average annual mortality: 4.4%), and 74% of these were cardiovascular. In age groups 40-49, 50-59, and 60-69 yr, odds ratio for cardiovascular mortality in patients vs. general population was 46.2, 20.1, and 8.0, respectively. Death from ischemic heart disease (IHD) was independently predicted by baseline congestive heart failure (relative risk: RR 5.33), diabetes (RR 2.28), systolic blood pressure (mmHg, RR 1.02), age (yr, RR 1.06), and high-density lipoprotein cholesterol (mmol/L, RR 0.36). Predictors for a major ischemic heart event (death from or onset of IHD) were in addition baseline total cholesterol (mmol/L, RR 1.18) and cerebrovascular disease (RR 2.98).

CONCLUSIONS

Thus, IHD was the major cause of death late after renal Tx, and a major ischemic heart event was predicted by baseline congestive heart failure, diabetes, age, hypertension, and hypercholesterolemia.

摘要

背景

尽管心血管疾病是肾移植(Tx)后主要的死亡原因,但心血管事件的预测因素尚未明确界定。这项横断面研究的目的首先是评估稳定的肾移植患者的心血管发病率和死亡率,并确定长期随访期间心血管事件的预测因素。

方法

总共406例肾移植患者(平均年龄:47岁,男性占60.1%,70.9%使用环孢素A)在肾移植后48个月开始进行基线登记(中位数),此后405例患者进行了5年随访。采用Kaplan-Meier曲线和多因素回归分析(Cox比例风险模型)来识别和描述心血管事件的预测因素。

结果

共有88例死亡(平均年死亡率:4.4%),其中74%为心血管原因导致。在40 - 49岁、50 - 59岁和60 - 69岁年龄组中,患者心血管死亡率与普通人群相比的比值比分别为46.2、20.1和8.0。缺血性心脏病(IHD)死亡的独立预测因素为基线充血性心力衰竭(相对风险:RR 5.33)、糖尿病(RR 2.28)、收缩压(mmHg,RR 1.02)、年龄(岁,RR 1.06)和高密度脂蛋白胆固醇(mmol/L,RR 0.36)。重大缺血性心脏事件(IHD死亡或发病)的预测因素还包括基线总胆固醇(mmol/L,RR 1.18)和脑血管疾病(RR 2.98)。

结论

因此,缺血性心脏病是肾移植后期主要的死亡原因,基线充血性心力衰竭、糖尿病、年龄、高血压和高胆固醇血症可预测重大缺血性心脏事件。

相似文献

1
Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.挪威稳定期肾移植患者的心血管疾病:5年随访期间的发病率和死亡率
Clin Transplant. 2004 Oct;18(5):596-604. doi: 10.1111/j.1399-0012.2004.00235.x.
2
Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.心血管风险与肾移植:肾移植中氟伐他汀评估(ALERT)研究的事后分析
Am J Kidney Dis. 2005 Sep;46(3):529-36. doi: 10.1053/j.ajkd.2005.05.014.
3
Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain.西班牙接受环孢素治疗的肾移植患者的缺血性心脏病
J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S286-90. doi: 10.1681/ASN.2006080928.
4
Hypertension as a risk factor for cardiovascular morbidity and mortality in an elderly German population; the prospective STEPHY II study. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly.高血压作为德国老年人群心血管发病和死亡的危险因素;前瞻性STEPHY II研究。施塔恩贝格老年帕金森病与高血压流行病学研究。
Eur Heart J. 1999 Dec;20(23):1752-6. doi: 10.1053/euhj.1999.1711.
5
Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.老年人未来致命性与非致命性冠心病事件的特征及基线临床预测因素:心血管健康研究
Circulation. 2006 May 9;113(18):2177-85. doi: 10.1161/CIRCULATIONAHA.105.610352. Epub 2006 May 1.
6
New-onset cardiovascular risk factors in lung transplant recipients.肺移植受者新发心血管危险因素
J Heart Lung Transplant. 2005 Oct;24(10):1536-43. doi: 10.1016/j.healun.2005.01.004.
7
Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study.
Clin Transplant. 2006 May-Jun;20(3):374-82. doi: 10.1111/j.1399-0012.2006.00496.x.
8
Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.肾功能不全预示着接受治疗的高血压患者中,高血糖所致缺血性心脏病死亡风险的降低。
Am J Hypertens. 2006 Oct;19(10):998-1004. doi: 10.1016/j.amjhyper.2006.03.010.
9
Incidence of cardiovascular risk factors and complications before and after kidney transplantation.肾移植前后心血管危险因素及并发症的发生率。
Transplant Proc. 2006 Mar;38(2):506-8. doi: 10.1016/j.transproceed.2006.01.001.
10
Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.泰国3499名城市居民队列中血脂与死亡原因的关联:泰国发电管理局(EGAT)研究
Angiology. 2007;58(6):757-63. doi: 10.1177/0003319707304042.

引用本文的文献

1
From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review.从风险评估到管理:肾移植受者术前及术后的心血管并发症:一篇叙述性综述
Diagnostics (Basel). 2025 Mar 21;15(7):802. doi: 10.3390/diagnostics15070802.
2
Framingham risk score is a useful indicator of posttransplant cardiovascular events and survival among Korean kidney transplant recipients: a nationwide, prospective cohort study.弗雷明汉风险评分是韩国肾移植受者移植后心血管事件和生存情况的有用指标:一项全国性前瞻性队列研究。
Kidney Res Clin Pract. 2025 Jul;44(4):679-692. doi: 10.23876/j.krcp.23.237. Epub 2024 Sep 13.
3
Systematic review and meta-analysis of the efficacy of exercise intervention in kidney transplant recipients.
系统评价和荟萃分析运动干预对肾移植受者疗效的影响。
World J Urol. 2023 Dec;41(12):3449-3469. doi: 10.1007/s00345-023-04673-9. Epub 2023 Oct 26.
4
Factors associated with a higher need for antihypertensive medications at 12-months in postkidney transplant recipients: a retrospective cohort study.肾移植受者术后12个月时与更高抗高血压药物需求相关的因素:一项回顾性队列研究。
Ann Med Surg (Lond). 2023 May 10;85(6):2362-2367. doi: 10.1097/MS9.0000000000000817. eCollection 2023 Jun.
5
GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.用肌酐而非胱抑素 C 估算的肾小球滤过率(GFR)更能反映肾移植受者低 GFR 不良结局的真实风险。
Nephrol Dial Transplant. 2023 Jul 31;38(8):1898-1906. doi: 10.1093/ndt/gfad007.
6
Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS).肾移植结局预测验证研究(TOPVAS)的人群特征与临床结果
J Clin Med. 2022 Dec 14;11(24):7421. doi: 10.3390/jcm11247421.
7
Hypertension in kidney transplant recipients.肾移植受者的高血压
World J Transplant. 2022 Aug 18;12(8):211-222. doi: 10.5500/wjt.v12.i8.211.
8
Clinical practice guideline exercise and lifestyle in chronic kidney disease.慢性肾脏病的临床实践指南:运动与生活方式
BMC Nephrol. 2022 Feb 22;23(1):75. doi: 10.1186/s12882-021-02618-1.
9
Risk of post-transplant cardiovascular events in kidney transplant recipients with preexisting aortoiliac stenosis.肾移植受者中预先存在的主髂动脉狭窄与移植后心血管事件风险。
Clin Transplant. 2022 Jan;36(1):e14515. doi: 10.1111/ctr.14515. Epub 2021 Nov 9.
10
Role of hypertension in kidney transplant recipients.高血压在肾移植受者中的作用。
J Hum Hypertens. 2021 Nov;35(11):958-969. doi: 10.1038/s41371-021-00540-5. Epub 2021 May 4.